GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2007

Bavarian Nordic and GSK Terminate Partnership on Smallpox Vaccine

  • Bavarian Nordic agreed with GlaxoSmithKline not to pursue a collaboration for the production and marketing of Imvamune®, a third-generation smallpox vaccine under development.

    The companies had previously signed a memorandum to ensure sufficient production capacity from several facilities and distribution of imvamune to various international markets at a time where Bavarian Nordic’s production facility was not established. Now Bavarian Nordic says it has the capacity to produce the expected RFP-III order.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Tackling Climate Change

Do you think most companies will respond positively to the People’s Climate March?